Antidepressant Prescribing Patterns in the Nursing Home: Second-Generation Issues Revisited

Abstract

Introduction The object of this study1 was to provide an updated evaluation of the quality of antidepressant management and prescribing patterns in nursing homes in the context of organizational and resident factors. Design Pearson correlation and chi-square analyses were conducted using information gathered from random nursing home charts. Setting Nursing home facilities in and around the Louisville, KY metropolitan area (N = 10). Participants Chart reviews were randomly chosen for 20% of long-term care resident records in participating homes (N = 209). Measurements Demographic information, documentation of depression diagnoses and antidepressant prescribing patterns were evaluated using the Quality of Depression Management and Antidepressant Prescribing rating (QDMAP) scale and information found the Minimum Data Set 2.0. Results 59.8% of the sample was prescribed antidepressants at the time of the chart review. 205 chart reviews indicated the absence or presence of a depression diagnosis, For those with documented depression diagnoses (n=126), nearly one quarter were not prescribed antidepressants. Out of 79 chart reviews indicating no depression diagnosis, nearly a third were receiving an antidepressant. Documentation related to changes in dosing, the presence or absence of side effects, or reasons for continuation were suboptimal. Conclusion Discrepancy between antidepressant prescribing and the presence/absence of depression diagnoses continue to exist for nursing home residents. The quality of antidepressant documentation in nursing home charts continues to be inadequate. Future research should aim to explore possible solutions to these discrepancies and deficiencies in documentation.

Depression and use of antidepressants in Swedish nursing homes: a 12-month follow-up study

“…This may well be the case in the present study, as 33% of all participants without diagnosed depression or a CSDD score of ࣙ8 were prescribed antidepressants, without an obvious indication, which is also consistent with another study (Shah et al, 2012).…”

Body mass index moderates the relationship between C-reactive protein and depressive symptoms: evidence from the China Health and Retirement Longitudinal Study

“…Furthermore, of the 6091 subjects included in this study, none reported taking antidepressants or receiving psychotherapy. However, the reported prevalence of antidepressant use in the United States ranges from 46–60% 45 . In Europe, this prevalence ranges from 23–45% 46 , and in Australia, the prevalence ranges from 21–33% 47 .…”

Use of antidepressant medications among older adults in European long-term care facilities: a cross-sectional analysis from the SHELTER study

“…However, depression is an independent risk factor for all-cause mortality in nursing homes [9] and it has been suggested that underuse of antidepressants is associated with increased disability, worsening of clinical outcomes and increased mortality [10]. Present guidelines recommend antidepressants and specifically selective serotonin reuptake inhibitors (SSRIs) as the first-line treatment of depression in older patients [11,12]. Previous studies have documented that prescription rates of psychotropic medications in NHs may be influenced by facility factors including the presence of a professional geriatrician [13].…”